Kincell Bio
United States
- Durham, NC
- 16/05/2025
- Unknown
- $22,000,000
Kincell Bio partners with innovators to advance autologous and allogeneic cell therapies for patients in need of therapeutic solutions. With manufacturing facilities located in Research Triangle Park, NC, and Gainesville, FL, Kincell Bio is a Cell therapy CDMO with the mission to streamline CMC development, apply expertise in analytical and process development, and facilitate quality-first, reliable GMP supply from early clinical to pivotal studies and product launch.
Kincell Bio’s platform offers clients a personalized, responsive, and expert-driven approach to process development and manufacturing from early clinical to pivotal supply and commercial launch, ensuring rapid timelines without compromising on quality.
- Industry Pharmaceutical Manufacturing
- Website https://kincellbio.com/
- LinkedIn https://www.linkedin.com/company/kincellbio/
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)